Drugs used in the treatment of women with breast cancer treated at a Brazilian reference Hospital
International Journal of Development Research
Drugs used in the treatment of women with breast cancer treated at a Brazilian reference Hospital
Received 30th April, 2021; Received in revised form 20th May, 2021; Accepted 18th June, 2021; Published online 25th July, 2021
Copyright © 2021, Cristina Albuquerque Douberin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The aim of this study was to identify the main symptomatic and chemotherapy medications used to treat women with breast cancer at Hospital do Cancer de Pernambuco; state of Pernambuco, Brazil. This was a descriptive, cross-sectional study, with a quantitative approach. Three hundred and seventeen women participated in the survey, who were interviewed in an outpatient clinic unit specialized in Mammary Pathology at Hospital do Cancer de Pernambuco, where, after consenting, they answered a questionnaire related to their clinical treatment. The data were described through the analysis (absolute numbers), isolated percentages, and intervals; then these data were demonstrated through tables. The results identified the medications that are part of participants' chemotherapy regimen, the main ones being Paclitaxel, Cyclophosphamide, and Doxorubicin.It was possible to notice that women used medications before chemotherapy, where the main ones are: Dexamethasone and Ondansetron.It was also observed that 107 women use other medications, in addition to those already mentioned, such as antihypertensives and antidiabetics.
